Versant Capital Management »

Zentalis Pharmaceuticals shares owned by Versant Capital Management

Quarter-by-quarter ownership of Zentalis Pharmaceuticals (ZNTL) shares owned by Versant Capital Management from 13F filings

Historical chart of Versant Capital Management investment in Zentalis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Zentalis Pharmaceuticals held by Versant Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zentalis Pharmaceuticals by Versant Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $725 46 15.76

More positions owned by Versant Capital Management

Avantis International Equity Etf Etf (AVDE)
Vanguard Emerging Markets Government Bond Etf Etf (VWOB)
Dimensional U.s. Core Equity 2 Etf Etf (DFAC)
Avantis Emerging Markets Equity Etf Etf (AVEM)
Flexshares Tr Mornstar Upstr Etf (GUNR)
Ishares S&p Global Energy Etf (IXC)
Microsoft Stock (MSFT)
Global X Fds Global X Ftse Greece 20 Etf Etf (GREK)
Vanguard Total Stk Mkt Etf (VTI)
Exxon Mobil Corp Stock (XOM)
Vaneck Gold Miners Etf Etf (GDX)
Dimensional Us Marketwide Value Etf Etf (DFUV)
Spdr Gold Minishares Trust Etf (GLDM)
Avantis U.s. Equity Etf Etf (AVUS)
Spdr S&p Global Natural Resources Etf Etf (GNR)

View all positions for Versant Capital Management

Top funds holding Zentalis Pharmaceuticals

Eventide Asset Management
Vanguard Group
Citadel Advisors
T. Rowe Price Associates
Federated Investors
Decheng Capital
PRIMECAP Management Company
Dimensional Fund Advisors
Bank of America Corporation
Logos Global Management
5AM Venture Management
Caption Management
Boxer Capital
Charles Schwab Investment Management
Paradigm Biocapital Advisors

View all funds holding Zentalis Pharmaceuticals